ENBREL
Active substance: etanercept
SOLUTION · ETANERCEPT 25 mg/.5mL
United StatesActive
Marketing holder: Immunex Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- ETANERCEPT · 25 mg/.5mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 10 |
|
| EU 6 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2e41-7c32-b411-423a30444c0c,01a120c3-71af-74ed-8d33-7daf62b2ee02,01a120c3-71e7-77a9-9c73-66f536aa364a,01a120c3-7af2-7c93-8a43-fa92b5b10843,01a120c3-819d-750c-b633-933c935cd96c;count=10 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-7dc8-77b3-acbc-ea63aed4560f,01a1208c-7dca-7890-bf76-6de2736f69af,01a1208d-4be9-74ae-b23f-b3186d592b00,01a1208e-855f-782d-ab7c-94591409828d,01a12091-ef1e-7dbc-a004-baa34b8e1cd4;count=5 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 58406-055
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
- product · openFDA NDC · 58406-055 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58406-055 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58406-055 · Verified 2026-10-09 · open in source